PHRM 845: Integrated Pharmacotherapy III

6 credits

Spring 2025 Lecture
Data from
Spring 2025
last updated 3/29/2025

This course will develop knowledge and skills regarding the physiology/ pathophysiology, medicinal chemistry, pharmacology, pharmacokinetics/pharmaceutics, and pharmacotherapy of specific cardiovascular diseases, neurology diseases, and psychiatric disorders.

Learning Outcomes

1Explain structure-function relationships of drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine, headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence.

2Explain the pharmacology of drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine, headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence.

3Describe the pathophysiologic processes responsible for specific disease states and integrate this knowledge into the therapeutic decision making process.

4Evaluate various therapeutic alternatives for a given disease state in light of specific patient factors and design a patient-specific pharmacotherapeutic regimen. This will include assessing the effectiveness of therapy on the basis of clinical and laboratory parameters.

5Describe adverse effects associated with drugs used for the management of ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine/headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence.

6Design evidence-based drug therapy treatment plans for patients with ischemic heart disease, heart failure, arrhythmias, Parkinson’s disease, dementia/Alzheimer’s disease, seizure disorders, MS, migraine/headache, psychotic disorders, bipolar disorder, depression, anxiety/sleep disorders, ADHD, pediatric psychiatric disorders, eating disorder, pain management, neuropathic pain, narcolepsy, and substance dependence.

Course PHRM 845 from Purdue University - West Lafayette.

Prerequisites

Restrictions

Program Doctor of Pharmacy-DP
Professionals (year 2)

GPA by professor

3.0
2.8

No grades available

No grades available

No grades available

No grades available

No grades available

No grades available

No grades available

No grades available

Other terms
Alex...(Spring 2019)

No grades available

Rich...(Spring 2019)

No grades available

Mich...(Spring 2019)

No grades available

Jenn...(Spring 2021)

No grades available

M

Noll L Campbell

001
12:30 pm
Lec
W

Noll L Campbell

001
12:30 pm
Lec
F

Noll L Campbell

001
12:30 pm
Lec

Community

Have something to say?

BoilerCoursesis an unofficial catalog for Purdue courses
made by Purdue students.
PHRM 845: Integrated Pharmacotherapy III